Systemic corticosteroids in acute chest syndrome: Friend or foe?

Paediatric Respiratory Reviews

Volumn 15, Issue 1, 2014, Pages 24-27

  Ogunlesi, Folasade ^a   Heeney, Matthew M ^b   Koumbourlis, Anastassios C ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Acute Chest Syndrome; Corticosteroids; Sickle Cell

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; METHYLPREDNISOLONE; PLACEBO; PREDNISOLONE; PREDNISONE; GLUCOCORTICOID;

ACUTE CHEST SYNDROME; ASTHMA; COMORBIDITY; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MEGADOSE; DRUG SAFETY; FAT EMBOLISM; HUMAN; INFLAMMATION; LOW DRUG DOSE; LUNG EMBOLISM; LUNG FAT EMBOLISM; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; REBOUND; REPERFUSION INJURY; REVIEW; RISK BENEFIT ANALYSIS; SYSTEMIC THERAPY; ANEMIA, SICKLE CELL; COMPLICATION; TREATMENT OUTCOME;

ACUTE CHEST SYNDROME; ANEMIA, SICKLE CELL; GLUCOCORTICOIDS; HUMANS; TREATMENT OUTCOME;

EID: 84893926193     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2013.10.004     Document Type: Review

References (42)

1. Hassell K.L. Population estimates of sickle cell disease in the U.S. American Journal of Preventive Medicine 2010, 38:S512-S521.
2. Miller A.C., Gladwin M.T. Pulmonary complications of sickle cell disease. Am J Respir Crit Care Med 2012, 185:1154-1165.
3. Gill F.M., Sleeper L.A., Weiner S.J., et al. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease. Blood 1995, 86:776-783.
4. Vishinsky E.P., Neumayr L.D., Earles A.N., et al. Causes and outcomes of acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 2000, 342:1855-1865.
5. Platt O.S. Sickle cell anemia as an inflammatory disease. J Clin Invest 2000, 106:337-338.
6. Wallace K.L., Marshall M.A., Ramos S.I., et al. NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-γ and CXCR3 chemokines. Blood 2009, 114:667-676.
7. Field J.J., Lin G., Okam M.M., et al. Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson. Blood 2013, 121:3329-3334.
8. Szczepanek S.M., McNamara J.T., Secor E.R., et al. Splenic morphological changes are accompanied by altered baseline immunity in a mouse model of sickle-cell disease. Am J Pathol 2012, 181:1725-1734.
9. Test S.T., Woolworth V.S. Defective regulation of complement by the sickle erythrocyte: evidence for a defect in control of membrane attack complex formation. Blood 1994, 83:842-852.
10. Kaul D.K., Hebbel R.P. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest 2000, 106:411-420.
11. Holtzclaw J.D., Jack D., Aguayo S.M., et al. Enhanced pulmonary and systemic response to endotoxin in transgenic sickle mice. Am J Respir Crit Care Med 2004, 169:687-695.
12. Belcher J.D., Mahaseth H., Welch T.E., et al. Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice. Am J Physiol Heart Circ Physiol 2005, 288:H2715-H2725.
13. Sabaa N., de Franceschi L., Bonnin P., et al. Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease. J Clin Invest 2008, 118:1924-1933.
14. Vichinsky E., Williams R., Das M., et al. Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia. Blood 1994, 83:3107-3112.
15. Ballas S.K., Files B., Luchtman-Jones L., et al. Secretory phospholipase A2 levels in patients with sickle cell disease and acute chest syndrome. Hemoglobin 2006, 30:165-170.
16. Godeau B., Schaeffer A., Bachir D., et al. Bronchoalveolar lavage in adult sickle cell patients with acute chest syndrome: value for diagnostic assessment of fat embolism. Am J Respir Crit Care Med 1996, 153:1691-1696.
17. Koumbourlis A.C., Santiago M.T., Mustafa U., et al. Lipid Laden Macrophages in bronchoalveolar lavage fluid: Aspiration or Infection?. Proc Am Thorac Soc 2006, 3:A166.
18. Newaskar M., Hardy K.A., Morris C.R. Asthma in sickle cell disease. Scientific World Journal 2011, 11:1138-1152.
19. Knight-Madden J.M., Forrester T.S., Lewis N.A., Greenough A. Asthma in children with sickle cell disease and its association with acute chest syndrome. Thorax 2005, 60:206-210.
20. Boyd J.H., Macklin E.A., Strunk R.C., et al. Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia. Blood 2006, 108:2923-2927.
21. Nordness M.E., Lynn J., Zacharisen M.C., et al. Asthma is a risk factor for acute chest syndrome and cerebral vascular accidents in children with sickle cell disease. Clin Mol Allergy 2005, 3:2.
22. Sylvester K.P., Patey R.A., Broughton S., et al. Temporal relationship of asthma to acute chest syndrome in sickle cell disease. Pediatr Pulmonol 2007, 42:103-106.
23. Hebbel R.P., Moldow C.F., Steinberg M.H. Modulation of erythrocyte-endothelial interactions and the vasocclusive severity of sickling disorders. Blood 1981, 58:947-952.
24. Turhan A., Weiss L.A., Mohandas N., et al. Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm. PNAS 2002, 99:3047-3051.
25. Francis R.B. Platelets, coagulation, and fibrinolysis in sickle cell disease: their possible role in vascular occlusion. Blood Coagul Fibrinolysis 1991, 2:341-353.
26. Setty B.N., Stuart M.J. Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: potential role in sickle cell disease. Blood 1996, 88:2311-2320.
27. Pujols L., Mullol J., Picado C. Importance of glucocorticoid receptors in upper and lower airways. Front Biosci 2010, 15:789-800.
28. Bruera E., Roca E., Cedaro L., et al. Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treat Rep 1985, 69:751-754.
29. Bederman S.S., Bhandari M., McKee M.D., et al. Do corticosteroids reduce the risk of fat embolism syndrome in patients with long-bone fractures?. A meta-analysis. Can J Surg 2009, 52:386-393.
30. Tang B.M., Craig J.C., Eslick G.D., et al. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med 2009, 37:1594-1603.
31. Griffin T.C., McIntire D., Buchanan G.R. High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease. N Engl J Med 1994, 330:733-737.
32. Bernini J.C., Rogers Z.R., Sandler E.S., et al. Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood 1998, 92:3082-3089.
33. Strouse J.J., Takemoto C.M., Keefer J.R., et al. Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease. Pediatr Blood Cancer 2007, 50:1006-1012.
34. Couillard S., Benkerrou M., Girot R., et al. Steroid treatment in children with sickle-cell disease. Haematologica 2007, 92:425-426.
35. Darbari D.S., Castro O., Taylor J.G., et al. Severe vaso-occlusive episodes associated with use of systemic corticosteroids in patients with sickle cell disease. J Natl Med Assoc 2008, 100:948-951.
36. Adler B.K., Salzman D.E., Carabasi M.H., et al. Fatal sickle cell crisis after granulocyte colony-stimulating factor administration. Blood 2001, 97:3313-3314.
37. Isakoff M.S., Lillo J.A., Hagstrom J.N. A single-institution experience with treatment of severe acute chest syndrome: lack of rebound pain with dexamethasone plus transfusion therapy. J Pediatr Hematol Oncol 2008, 30:322-325.
38. Quinn C.T., Stuart M.J., Kesler K., et al. Investigators of the Comprehensive Sickle Cell Centers. Tapered oral dexamethasone for the acute chest syndrome of sickle cell disease. Br J Haematol 2011, 155:263-267.
39. Sobota A., Graham D.A., Heeney M.M., et al. Corticosteroids for acute chest syndrome in children with sickle cell disease: Variation in use and association with length of stay and readmission. Am J Hematol 2010, 85:24-28.
40. Sobota A., Graham D.A., Neufeld E.J., Heeney M.M. Thirty-day readmission rates following hospitalization for pediatric sickle cell crisis at freestanding children's hospitals: risk factors and hospital variation. Pediatr Blood Cancer 2012, 58:61-65.
41. Liem R.I., O'Gorman M.R., Brown D.L. Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome. Am J Hematol 2004, 76:19-25.
42. Hsu LL, Gee BE. Sickle Cell Pain After Abrupt Withdrawal of Glucocorticoids for Asthma. 2010: A6207, 10.1164/ajrccm-conference.2010.181.1 Meeting Abstracts. A6207.